Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Cash Flow-to-Debt Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥11.07 Million could theoretically repay 0% of its total liabilities (CN¥269.87 Million) in one year. See Jiangsu Jibeier Pharmaceutical Co Ltd (688566) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Jiangsu Jibeier Pharmaceutical Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Jiangsu Jibeier Pharmaceutical Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Jiangsu Jibeier Pharmaceutical Co Ltd. Check Jiangsu Jibeier Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥248.30 Million | CN¥267.47 Million | ▲ +18.0% |
| 2024 | 0.79x | CN¥215.29 Million | CN¥273.68 Million | ▲ +47.6% |
| 2023 | 0.53x | CN¥159.50 Million | CN¥299.25 Million | ▼ -4.4% |
| 2022 | 0.56x | CN¥150.72 Million | CN¥270.24 Million | ▼ -22.1% |
| 2021 | 0.72x | CN¥150.56 Million | CN¥210.40 Million | ▲ +4.2% |
| 2020 | 0.69x | CN¥117.36 Million | CN¥170.92 Million | ▼ -25.6% |
| 2019 | 0.92x | CN¥115.45 Million | CN¥125.16 Million | ▲ +13.3% |
| 2018 | 0.81x | CN¥97.97 Million | CN¥120.32 Million | ▼ -36.6% |
| 2017 | 1.28x | CN¥111.66 Million | CN¥86.92 Million | ▲ +289.1% |
| 2016 | 0.33x | CN¥39.29 Million | CN¥118.99 Million | — |